| A novel retinoblastoma therapy from genomic and epigenetic analyses J Zhang, CA Benavente, J McEvoy, J Flores-Otero, L Ding, X Chen, ... Nature 481 (7381), 329-334, 2012 | 574 | 2012 |
| Targeting the DNA repair pathway in Ewing sarcoma E Stewart, R Goshorn, C Bradley, LM Griffiths, C Benavente, NR Twarog, ... Cell reports 9 (3), 829-840, 2014 | 179 | 2014 |
| Genetics and epigenetics of human retinoblastoma CA Benavente, MA Dyer Annual Review of Pathology: Mechanisms of Disease 10 (1), 547-562, 2015 | 145 | 2015 |
| Single cell transcriptomics of human epidermis identifies basal stem cell transition states S Wang, ML Drummond, CF Guerrero-Juarez, E Tarapore, AL MacLean, ... Nature communications 11 (1), 4239, 2020 | 142 | 2020 |
| Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes CA Benavente, EL Jacobson Free Radical Biology and Medicine 44 (4), 527-537, 2008 | 82 | 2008 |
| Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin CA Benavente, SA Schnell, EL Jacobson Public Library of Science 7 (7), e42276, 2012 | 75 | 2012 |
| NAD in skin: therapeutic approaches for niacin CA Benavente, MK Jacobson, EL Jacobson Current pharmaceutical design 15 (1), 29-38, 2009 | 73 | 2009 |
| Subcellular distribution and mitogenic effect of basic fibroblast growth factor in mesenchymal uncommitted stem cells CA Benavente, WD Sierralta, PA Conget, JJ Minguell Growth Factors 21 (2), 87-94, 2003 | 53 | 2003 |
| Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression CA Benavente, D Finkelstein, DA Johnson, JC Marine, R Ashery-Padan, ... Oncotarget 5 (20), 9594, 2014 | 47 | 2014 |
| Cross-species genomic and epigenomic landscape of retinoblastoma CA Benavente, JD McEvoy, D Finkelstein, L Wei, G Kang, YD Wang, ... Oncotarget 4 (6), 844, 2013 | 45 | 2013 |
| The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells L Zocchi, SC Wu, J Wu, KL Hayama, CA Benavente Oncotarget 9 (34), 23505, 2018 | 39 | 2018 |
| Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma I Aldiri, I Ajioka, B Xu, J Zhang, X Chen, C Benavente, D Finkelstein, ... Development 142 (23), 4092-4106, 2015 | 38 | 2015 |
| Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation Y Bermudez, CA Benavente, RG Meyer, WR Coyle, MK Jacobson, ... PLoS One 6 (5), e20487, 2011 | 37 | 2011 |
| Chromatin remodeling protein HELLS is critical for retinoblastoma tumor initiation and progression L Zocchi, A Mehta, SC Wu, J Wu, Y Gu, J Wang, S Suh, RC Spitale, ... Oncogenesis 9 (2), 25, 2020 | 36 | 2020 |
| Retinoblastoma tumor suppressor protein roles in epigenetic regulation F Guzman, Y Fazeli, M Khuu, K Salcido, S Singh, CA Benavente Cancers 12 (10), 2807, 2020 | 33 | 2020 |
| Chromatin remodeling protein HELLS is upregulated by inactivation of the RB-E2F pathway and is nonessential for osteosarcoma tumorigenesis SC Wu, CA Benavente Oncotarget 9 (66), 32580, 2018 | 22 | 2018 |
| UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression SC Wu, A Kim, Y Gu, DI Martinez, L Zocchi, CC Chen, J Lopez, K Salcido, ... Oncogenesis 11 (1), 51, 2022 | 17 | 2022 |
| Heavenly HELLS? A potential new therapeutic target for retinoblastoma L Zocchi, SC Wu, CA Benavente Oncoscience 7 (3-4), 23, 2020 | 3 | 2020 |
| Genetically engineered mouse and orthotopic human tumor xenograft models of retinoblastoma CA Benavente, MA Dyer Mouse Models of Cancer: Methods and Protocols, 307-317, 2015 | 3 | 2015 |
| DNA Repair and Epigenetics in Cancer L Zocchi, CA Benavente Molecular Medicines for Cancer, 529-562, 2018 | 1* | 2018 |
Amos LohSenior Consultant, KK Women's and Children's HospitVerified email at kkh.com.sg
